| [1] REICHENBACH H,HOFLE G.Biologically Active Secondary Metabolites from Myxobacteria [J].Biotech. Adv.,1993,11:219-277.[2] GERTH K,PRADELLA S,PERLOVA O，et al.Myxobacteria:Proficient Producers of Novel Natural Products with Various Biological Activities-Past and Future Biotechnological Aspects with the Focus on the Genus Sorangium [J].J. Biotech.,2003,106:233-253.[3] HARDT I H,STEINMETZ H,GERTH K.New Natural Epothilones from Sorangium Cellulosum,Strains So ce90/B2 and So ce90/D13:Isolation,Structure Elucidation,and SAR Studies [J].J. Nat. Prod.,2001,64（7）：847-856.[4] GERTH K,BEDORF N,HOFLE G，et al.Epothilones A and B:Antifungal and Cytotoxic Compounds from Sorangium Cellulosum (Myxobacteria) [J].J. Antibiot,1996,49:560-563.[5] SHIMKETS L,WOESE C R.A Phylogenetic Analysis of the Myxobacteria:Basis for Their Classification [J].Procd. Nat. Aca. Sci. USA,1992,89:9 459-9 463.[6] BEYER S,KUNZE B,SILAKOWSKI B，et al.Metabolic Diversity in Myxobacteria:Identification of the Myxalamid and the Stigmatellin Biosynthetic Gene Cluster of Stigmatella Aurantiaca Sg a15 and a Combined Polyketide-(Poly) Peptide Gene Cluster from the Epothilone Producing Strain Sorangium Cellulosum So ce90 [J].Biochim. Bioph. Acta.,1999,1 445:185-195.[7] CHOU T C,ZHANG X G,BALOG A，et al.Desoxyepothilone B:An Efficacious Microtubule-Targeted Antitumor Agent with a Promising in Vivo Profile Relative to Epothilone B [J].Procd. Nat. Aca. Sci. USA,1998,95:4 296-4 796.[8] SONG Xiang-rang，WEI Ling，WANG Xing-wu，et al.The Chemotherapy Sensitivity and Gene Expression in Lung Cancer Cell Lines [J].Cancer. Res. Prev. Treat.,2006,33（1）:1-4.[9] LI Yu-xiu，LIN Zhi-bin，TAN Huan-ran.Studies on the Relationship of Apotosis and Multidrug Resistance in 5-Fluorouaacil Resistant Human Hepatocellular Carcinoma Cell Line Bel7402/5-FU [J].Chinese Pharm. Bull.,2003,19（5）:512-517. |
